Law ❯ Litigation ❯ Securities Litigation ❯ Class Action Lawsuits

Investor Rights

Securities Suit Targets Capricor Over FDA Findings on Trial Analysis

Regulators have extended their review after finding Capricor’s post‑study changes to its statistical plan made some analyses effectively post‑hoc.

Investors File Securities Suit Against Grail as Firms Race for Lead‑Plaintiff Role

Lead-Plaintiff Deadline Nears in Alight Securities Lawsuit

Trip.com Faces U.S. Securities Class Action Over Antitrust Risk Disclosures

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety and Launch Claims

Sallie Mae Investors Face Feb. 17 Deadline to Seek Lead in Securities Fraud Suit

DeFi Technologies Investors Face Jan. 30 Deadline in EDNY Securities Class Action

SLM Securities Class Action Enters Lead-Plaintiff Phase Ahead of Feb. 17 Deadline

Law Firms Urge SLM Investors to Seek Lead Role Before Feb. 17 in New Jersey Securities Case

Coupang Hit With New Investor Suits as Class Period Expands in Data-Breach Case

Sallie Mae Faces Securities Class Action Over Alleged Hidden Delinquency Spike

aTyr Investors Face Dec. 8 Deadline as Rival Lawsuits Over Failed Sarcoidosis Trial Intensify

Perrigo Sued in Securities Class Action Over Infant-Formula Disclosures as Law Firms Recruit Lead Plaintiffs

Synopsys Investors Warned of Dec. 30 Lead-Plaintiff Deadline in Securities Class Action Over Design IP Disclosures

Firefly Aerospace Faces Securities Class Action Over IPO Disclosures

Inspire Medical Hit With Securities Class Action Over Inspire V Launch as Firms Court Lead Plaintiffs

LifeMD Securities Case Reaches Lead-Plaintiff Deadline as Firms Court Investors

KBR Investors Pressed to Seek Lead Role in Securities Case After DoD Contract Loss

Sable Offshore Investors Face Sept. 26 Deadline in Securities Class Action

RxSight Securities Suit Nears Lead-Plaintiff Deadline After 38% Stock Plunge